Cited by 700Diabetes Management and ResearchDiabetes and associated disordersDiabetes Management and Education

Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood

Open access
Dabelea, Dana, Stafford, Jeanette M., Mayer-Davis, Elizabeth J., D’Agostino, Ralph, Dolan, Lawrence, Imperatore, Giuseppina, Linder, Barbara, Lawrence, Jean M. +8 more·2017·JAMA

Abstract

Importance: The burden and determinants of complications and comorbidities in contemporary youth-onset diabetes are unknown. Objective: To determine the prevalence of and risk factors for complications related to type 1 diabetes vs type 2 diabetes among teenagers and young adults who had been diagnosed with diabetes during childhood and adolescence. Design, Setting, and Participants: Observational study from 2002 to 2015 in 5 US locations, including 2018 participants with type 1 and type 2 diabetes diagnosed at younger than 20 years, with single outcome measures between 2011 and 2015. Exposures: Type 1 and type 2 diabetes and established risk factors (hemoglobin A1c level, body mass index, waist-height ratio, and mean arterial blood pressure). Main Outcomes and Measures: Diabetic kidney disease, retinopathy, peripheral neuropathy, cardiovascular autonomic neuropathy, arterial stiffness, and hypertension. Results: Of 2018 participants, 1746 had type 1 diabetes (mean age, 17.9 years [SD, 4.1]; 1327 non-Hispanic white [76.0%]; 867 female patients [49.7%]), and 272 had type 2 (mean age, 22.1 years [SD, 3.5]; 72 non-Hispanic white [26.5%]; 181 female patients [66.5%]). Mean diabetes duration was 7.9 years (both groups). Patients with type 2 diabetes vs those with type 1 had higher age-adjusted prevalence of diabetic kidney disease (19.9% vs 5.8%; absolute difference [AD], 14.0%; 95% CI, 9.1%-19.9%; P < .001), retinopathy (9.1% vs 5.6%; AD, 3.5%; 95% CI, 0.4%-7.7%; P = .02), peripheral neuropathy (17.7% vs 8.5%; AD, 9.2%; 95% CI, 4.8%-14.4%; P < .001), arterial stiffness (47.4% vs 11.6%; AD, 35.9%; 95% CI, 29%-42.9%; P < .001), and hypertension (21.6% vs 10.1%; AD, 11.5%; 95% CI, 6.8%-16.9%; P < .001), but not cardiovascular autonomic neuropathy (15.7% vs 14.4%; AD, 1.2%; 95% CI, -3.1% to 6.5; P = .62). After adjustment for established risk factors measured over time, participants with type 2 diabetes vs those with type 1 had significantly higher odds of diabetic kidney disease (odds ratio [OR], 2.58; 95% CI, 1.39-4.81; P=.003), retinopathy (OR, 2.24; 95% CI, 1.11-4.50; P = .02), and peripheral neuropathy (OR, 2.52; 95% CI, 1.43-4.43; P = .001), but no significant difference in the odds of arterial stiffness (OR, 1.07; 95% CI, 0.63-1.84; P = .80) and hypertension (OR, 0.85; 95% CI, 0.50-1.45; P = .55). Conclusions and Relevance: Among teenagers and young adults who had been diagnosed with diabetes during childhood or adolescence, the prevalence of complications and comorbidities was higher among those with type 2 diabetes compared with type 1, but frequent in both groups. These findings support early monitoring of youth with diabetes for development of complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2017.0686

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Statin benefit for CVD is not evident in dialysis-dependent persons.

    “However, the beneficial effect of statins is not apparent in persons who require dialysis.333,357,411–413”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [413]

    The Diabetic Kidney Disease section defines kidney disease using albuminuria or reduced estimated glomerular filtration rate, while the Results compare complications in young people with type 1 and type 2 diabetes. Searches for statins, dialysis, and cardiovascular benefit found no passage addressing whether statins benefit people who require dialysis. Page numbers were not available in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Diabetes during pregnancy predisposes offspring for the development of obesity, type 2 diabetes and cardiometabolic disease risk factors.

    “Diabetes during pregnancy also predisposes offspring for the development of obesity, T2D and cardiometabolic disease risk factors [33,70,71,72,73,74,75,76,77] (Figure 1).”

    From Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease (2022) · cites this paper as [77]

    The Abstract and Discussion compare complications and cardiovascular risk factors in young people with type 1 versus type 2 diabetes. Searches for maternal diabetes, pregnancy, and in-utero exposure found no passage addressing whether diabetes during pregnancy predisposes offspring to obesity, type 2 diabetes, or cardiometabolic risk factors. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., Black, M. H., Pop-Busui, R., Saydah, S., Hamman, R. F., Pihoker, C., & for the SEARCH for Diabetes in Youth Research Group
Affiliations
  • Colorado School of Public Health (US)
  • Wake Forest University Health Sciences (US)
  • University of North Carolina at Chapel Hill (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Centers for Disease Control and Prevention (US)
  • National Institutes of Health (US)
  • Kaiser Permanente (US)
  • University of Washington (US)
  • Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor
Corresponding author
Dabelea, Dana
Venue
JAMA
Published
2017-02-28
Volume
317
Issue
8
Pages
825
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2593912695
Cited by
700
References
44
Citations by year
2026: 48 · 2025: 81 · 2024: 79 · 2023: 89 · 2022: 97 · 2021: 74 · 2020: 77 · 2019: 62 · 2018: 65 · 2017: 27 · 2016: 1
FWCI
49.90
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Medical University of South Carolina
  • Cincinnati Children's Hospital Medical Center
  • University of Washington
  • University of South Carolina
  • Seattle Children's Research Institute
  • Greenville Health System
  • National Institutes of Health (UL1TR000154, UL1TR000423, UL1TR001425, UL1TR001450, UL1TR002319)
  • Centers for Disease Control and Prevention
  • University of North Carolina at Chapel Hill
  • Wake Forest School of Medicine
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, K23DK093804, UC4DK108173, P30DK056350)
  • National Center for Chronic Disease Prevention and Health Promotion (U01 DP-000247, U18 DP-002709, U18 DP006134, U18-DP-002708, U01-DP000246, U01-DP-000250, U01-DP-000254, U18 DP002714, U18 DP006139, U01 DP000248, U18 DP006138, U18 DP006136, U18 DP006131, U18 DP006133, U01DP000244, U18 DP002710)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 1 diabetes, type 2 diabetes, youth-onset diabetes, diabetes complications, diabetic nephropathy, diabetic retinopathy, peripheral neuropathy, cardiac autonomic neuropathy, arterial stiffness, hypertension, comorbidities, young adults, glycemic control, HbA1c, body mass index, waist-to-height ratio, blood pressure, risk factors, complication prevalence
MeSH terms
Adolescent, Blood Pressure, Child, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypertension, Male, Risk Factors, Body Mass Index, Prevalence, Age of Onset, Diabetes Complications, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review